Genomma Lab Internacional SAB de CV Stock | LABB.MX | MX01LA010006 | A0Q4TC | July 2025

Date	Genomma Lab Internacional SAB de CV Price
7/28/2025	0 undefined
7/24/2025	20.90 undefined
7/23/2025	20.65 undefined
7/22/2025	20.91 undefined
7/21/2025	20.67 undefined
7/20/2025	21.28 undefined
7/17/2025	20.45 undefined
7/16/2025	20.60 undefined
7/15/2025	20.91 undefined
7/14/2025	20.20 undefined
7/13/2025	19.95 undefined
7/10/2025	20.16 undefined
7/9/2025	19.96 undefined
7/8/2025	19.97 undefined
7/7/2025	20.52 undefined
7/6/2025	20.31 undefined
7/3/2025	20.61 undefined
7/2/2025	20.35 undefined
7/1/2025	20.64 undefined
6/30/2025	20.53 undefined
6/29/2025	20.45 undefined

Date	Genomma Lab Internacional SAB de CV Revenue	Genomma Lab Internacional SAB de CV EBIT	Genomma Lab Internacional SAB de CV Net Income
2029e	26.35 B undefined	5.76 B undefined	3.65 B undefined
2028e	23.68 B undefined	5.37 B undefined	3.22 B undefined
2027e	23.07 B undefined	5.12 B undefined	3.23 B undefined
2026e	21.15 B undefined	4.72 B undefined	2.67 B undefined
2025e	20.13 B undefined	4.46 B undefined	2.4 B undefined
2024	18.61 B undefined	3.91 B undefined	1.49 B undefined
2023	16.47 B undefined	3.21 B undefined	1.03 B undefined
2022	16.82 B undefined	3.24 B undefined	1.39 B undefined
2021	15.49 B undefined	3.06 B undefined	1.31 B undefined
2020	13.87 B undefined	2.77 B undefined	1.4 B undefined
2019	12.71 B undefined	2.33 B undefined	749.61 M undefined
2018	11.79 B undefined	2.42 B undefined	1.11 B undefined
2017	12.08 B undefined	2.58 B undefined	1.28 B undefined
2016	11.32 B undefined	286.61 M undefined	-1.68 B undefined
2015	11.04 B undefined	-975.22 M undefined	-1.07 B undefined
2014	11.54 B undefined	2.45 B undefined	1.44 B undefined
2013	11.36 B undefined	2.93 B undefined	1.75 B undefined
2012	9.8 B undefined	2.49 B undefined	1.57 B undefined
2011	8.08 B undefined	2.06 B undefined	1.4 B undefined
2010	6.26 B undefined	1.62 B undefined	1.07 B undefined
2009	4.43 B undefined	1.09 B undefined	759 M undefined
2008	2.63 B undefined	673 M undefined	516 M undefined
2007	1.87 B undefined	453 M undefined	304 M undefined
2006	1.43 B undefined	279 M undefined	180 M undefined
2005	693 M undefined	-126 M undefined	-114 M undefined

	Revenue	EBIT	Net Income
2005	693 M MXN	-126 M MXN	-114 M MXN
2006	1.43 B MXN	279 M MXN	180 M MXN
2007	1.87 B MXN	453 M MXN	304 M MXN
2008	2.63 B MXN	673 M MXN	516 M MXN
2009	4.43 B MXN	1.09 B MXN	759 M MXN
2010	6.26 B MXN	1.62 B MXN	1.07 B MXN
2011	8.08 B MXN	2.06 B MXN	1.4 B MXN
2012	9.8 B MXN	2.49 B MXN	1.57 B MXN
2013	11.36 B MXN	2.93 B MXN	1.75 B MXN
2014	11.54 B MXN	2.45 B MXN	1.44 B MXN
2015	11.04 B MXN	-975.22 M MXN	-1.07 B MXN
2016	11.32 B MXN	286.61 M MXN	-1.68 B MXN
2017	12.08 B MXN	2.58 B MXN	1.28 B MXN
2018	11.79 B MXN	2.42 B MXN	1.11 B MXN
2019	12.71 B MXN	2.33 B MXN	749.61 M MXN
2020	13.87 B MXN	2.77 B MXN	1.4 B MXN
2021	15.49 B MXN	3.06 B MXN	1.31 B MXN
2022	16.82 B MXN	3.24 B MXN	1.39 B MXN
2023	16.47 B MXN	3.21 B MXN	1.03 B MXN
2024	18.61 B MXN	3.91 B MXN	1.49 B MXN
2025e	20.13 B MXN	4.46 B MXN	2.4 B MXN
2026e	21.15 B MXN	4.72 B MXN	2.67 B MXN
2027e	23.07 B MXN	5.12 B MXN	3.23 B MXN
2028e	23.68 B MXN	5.37 B MXN	3.22 B MXN
2029e	26.35 B MXN	5.76 B MXN	3.65 B MXN

2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024

0.08	0.05	0.06	1.32	1.08	1.45	1.54	0.88	1.76	1.16	1.73	1.85	1.09	1.41	0.9	2.05	1.22	1.5	1.47	2.28
0.25	0.48	0.6	0.87	1.27	1.94	3.6	4.8	5.02	4.16	2.07	2.49	2.75	2.92	3.44	4.03	4.23	4.27	3.71	4.44
0	0	0	-0.11	0.27	0.23	0.05	0.47	0.68	1.31	1.85	1.87	2.26	2.4	2.87	3.28	3.17	2.49	2.53	2.19
0.07	0.15	0.23	0.41	0.63	0.95	1.1	1.03	1.44	1.6	1.16	1.17	1.26	1.7	1.91	2.05	2.2	2.4	1.91	2.18
0.03	0.02	0.03	0.13	0.12	0.12	0.33	1.03	1.09	0	0.73	0.42	0.48	0.57	0.7	0.63	0.7	0.65	1.01	0.98
0.43	0.7	0.92	2.62	3.37	4.68	6.63	8.22	9.99	8.23	7.54	7.8	7.84	9	9.82	12.04	11.52	11.31	10.64	12.07
0.03	0.03	0.05	0.11	0.26	0.43	0.43	0.4	0.41	0.46	0.41	0.37	0.55	1.87	2.22	2.85	3.37	3.59	3.41	3.56
0	0	0.08	0	0	0.01	0.01	0.01	0.02	0.02	1.35	1.42	1.47	1.56	0.91	0.91	0.77	0.79	0.73	0
0	1	79	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
0	0	0	0	0	0	0.05	4.34	6.86	7.06	6.47	5.26	5.18	4.94	4.91	4.91	5.17	5.15	4.95	5.93
0	0	0	0	0	0	0	0	0	0	45	45	0	51.95	0	0	0	0	0	0
0.02	0.01	0.07	0.11	0.61	0.72	2.08	0.03	0.08	0.73	1.82	0.82	0.84	0.67	0.67	0.63	0.72	0.76	0.96	1.47
0.05	0.04	0.28	0.22	0.87	1.15	2.57	4.78	7.37	8.27	10.09	7.91	8.05	9.08	8.71	9.3	10.02	10.29	10.06	10.95
0.48	0.73	1.19	2.84	4.24	5.83	9.19	12.99	17.35	16.5	17.63	15.71	15.89	18.08	18.53	21.34	21.54	21.61	20.7	23.02

0.27	0.27	0.27	0.28	0.28	1.93	1.93	1.92	1.91	1.91	1.91	1.91	1.91	1.91	1.91	1.91	1.91	1.91	1.86	1.83
0	0	0	1.55	1.55	0	0	0.04	0.04	0.04	0.04	0.04	0.04	0.04	0.04	0.04	0.04	0.04	0.04	0.04
-0.03	0.15	0.4	0.48	1.21	2.16	3.53	5.16	6.82	8.26	7.61	5.51	5.99	6.81	6.76	8.09	9.42	10.05	10.77	11.51
-73	-74	-78	4	1	-7	66	5	13	12.83	0	768.78	559.48	97.67	50.04	-53.81	-135.77	-147.71	-1,494.86	-753.47
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2.34	2.34	2.34	2.34
0.17	0.35	0.58	2.31	3.04	4.08	5.53	7.12	8.79	10.23	9.57	8.24	8.51	8.86	8.76	9.99	11.24	11.85	11.18	12.63
0.16	0.11	0.08	0.38	0.59	0.97	1.26	1.22	1.64	1.55	0.67	1.03	1.1	1.77	1.88	1.64	1.44	1.79	1.84	1.73
0.09	0.1	0.15	0	0	0.01	0.02	0	0.01	0.18	0.03	0	0.01	0.01	0.04	0.03	0.03	0.04	1.06	1.61
0	0.04	0.09	0.14	0.43	0.57	0.9	1	0.7	5.46	1.45	1.99	2.18	2.03	2.19	2.93	3	2.67	1.73	1.82
44	111	257	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
0	0	0	0	0	0	0	0.41	0.81	0.4	0.35	2.07	3.01	0.68	1.57	2.01	2.11	4.85	2.01	1.38
0.3	0.37	0.58	0.52	1.03	1.55	2.19	2.63	3.15	7.6	2.5	5.1	6.31	4.49	5.68	6.61	6.57	9.36	6.64	6.54
0	0	0	0	0	0	0.97	3.05	4.65	6.51	5.83	3.76	1.69	5.2	4.53	4.47	3.86	1.59	4.23	5.11
10	17	20	0	46	67	180	229	660	756.92	1.7	2.27	1.69	100.37	214.82	551.64	554.7	392.73	326.36	379.55
3	5	7	5	116	104	286	62	52	67.12	57.52	52.59	840.27	866.4	856.45	858.29	489.14	115.08	114.5	102.38
0.01	0.02	0.03	0.01	0.16	0.17	1.44	3.34	5.36	7.33	5.89	3.82	2.53	6.16	5.6	5.88	4.9	2.1	4.67	5.59
0.31	0.39	0.61	0.53	1.19	1.72	3.62	5.97	8.52	14.93	8.38	8.92	8.84	10.65	11.28	12.5	11.47	11.45	11.31	12.13
0.48	0.73	1.19	2.84	4.23	5.8	9.15	13.1	17.3	25.16	17.95	17.15	17.34	19.51	20.04	22.48	22.71	23.31	22.49	24.76

2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
-0.12	0.18	0.31	0.54	1.08	1.58	2.03	1.61	2.61	2.12	-1.01	-1.64	1.41	1.11	0.76	1.47	1.31	1.39	1.03
9	8	7	18	32	78	81	66	64	98	118	83	69	81	142	158	170	227	271
-58	12	5	192	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
0.13	-0.31	-0.26	-0.32	-0.76	-0.82	-2.08	-1.96	-1.05	-0.1	-0.13	1.03	-0.14	0.26	0.11	0.01	-0.34	0.3	0.16
0.05	0.01	0.05	-0.2	0.01	0.5	0.05	0.18	0.25	-1.08	2.21	2.07	0.05	0.11	-0.01	0.07	0.33	0.14	0.79
0	0	0	19	0	0	28	162	278	331	343	356	470	586	660	467	484	627	811
0	0	0	265	196	135	346	186	262	376	456	966	416	664	332	751	838	706	981
0.02	-0.1	0.11	0.23	0.36	1.33	0.09	-0.11	1.87	1.04	1.19	1.54	1.39	1.56	1.01	1.71	1.47	2.05	2.25
-6	-11	-32	-127	-178	-419	-968	-2,688	-2,731	-904	-127	-158	-311	-1,512	-876	-704	-836	-422	-335
13	-6	-172	-124	-524	-418	-974	-2,687	-2,722	-2,759	862	140	-208	-1,366	-844	-663	-765	-282	-165
19	5	-140	2	-345	0	-6	1	9	-1,855	990	298	103	145	31	40	71	140	169
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
0.01	0.07	0.15	-0.26	0	0	0.97	2.49	2.04	1.47	-0.72	-0.35	-1.14	1.16	0.09	0.36	-0.58	0.45	-0.12
-0.18	0	0	1.52	-0.07	-0.05	-0.04	-0.07	-0	-0.01	-0.52	-1.08	-0	-0.13	-0.08	-0.01	-0.16	-0.53	-0.14
-0.17	0.07	0.08	1.14	-0.06	-0.53	0.9	2.23	1.77	1.15	-1.58	-1.65	-1.69	0.47	-0.62	0.19	-1.47	-1.36	-1.68
0	-1	0	-19	6	-484	-33	-189	-267	-307	-337	-225	-554	-554	-632	-157	-341	-498	-830
0	0	-61	-95	0	0	0	0	0	0	0	0	0	0	0	0	-391	-777	-580
-0.14	-0.04	0.02	1.25	-0.24	0.38	0.08	-0.62	0.85	-0.58	0.54	0.12	-0.75	0.32	-0.49	1.18	-0.84	0.24	0.17
12.2	-106.9	73.9	101.9	177	912.8	-879.4	-2,796	-861.1	134.5	1,060.4	1,385.35	1,081.03	50.2	130.33	1,009.9	631.56	1,632.36	1,918.85
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0

Genomma Lab Internacional SAB de CV Gross margin	Genomma Lab Internacional SAB de CV Profit margin	Genomma Lab Internacional SAB de CV EBIT margin	Genomma Lab Internacional SAB de CV Profit margin
2029e	64.12 %	21.88 %	13.85 %
2028e	64.12 %	22.68 %	13.59 %
2027e	64.12 %	22.17 %	14.02 %
2026e	64.12 %	22.3 %	12.63 %
2025e	64.12 %	22.16 %	11.9 %
2024	64.12 %	21.03 %	8.02 %
2023	61.23 %	19.48 %	6.23 %
2022	60.43 %	19.28 %	8.26 %
2021	61.75 %	19.73 %	8.44 %
2020	61.92 %	19.96 %	10.12 %
2019	63.7 %	18.34 %	5.9 %
2018	65.83 %	20.56 %	9.41 %
2017	67.24 %	21.4 %	10.59 %
2016	67.88 %	2.53 %	-14.85 %
2015	65.8 %	-8.83 %	-9.68 %
2014	69.34 %	21.19 %	12.52 %
2013	69.92 %	25.8 %	15.42 %
2012	68.76 %	25.43 %	15.97 %
2011	69.5 %	25.47 %	17.3 %
2010	71.02 %	25.78 %	17.13 %
2009	72.02 %	24.66 %	17.15 %
2008	74.82 %	25.6 %	19.63 %
2007	73.36 %	24.19 %	16.23 %
2006	75.79 %	19.52 %	12.6 %
2005	78.07 %	-18.18 %	-16.45 %

	Gross margin	EBIT margin	Profit margin
2005	78.07 %	-18.18 %	-16.45 %
2006	75.79 %	19.52 %	12.6 %
2007	73.36 %	24.19 %	16.23 %
2008	74.82 %	25.6 %	19.63 %
2009	72.02 %	24.66 %	17.15 %
2010	71.02 %	25.78 %	17.13 %
2011	69.5 %	25.47 %	17.3 %
2012	68.76 %	25.43 %	15.97 %
2013	69.92 %	25.8 %	15.42 %
2014	69.34 %	21.19 %	12.52 %
2015	65.8 %	-8.83 %	-9.68 %
2016	67.88 %	2.53 %	-14.85 %
2017	67.24 %	21.4 %	10.59 %
2018	65.83 %	20.56 %	9.41 %
2019	63.7 %	18.34 %	5.9 %
2020	61.92 %	19.96 %	10.12 %
2021	61.75 %	19.73 %	8.44 %
2022	60.43 %	19.28 %	8.26 %
2023	61.23 %	19.48 %	6.23 %
2024	64.12 %	21.03 %	8.02 %
2025e	64.12 %	22.16 %	11.9 %
2026e	64.12 %	22.3 %	12.63 %
2027e	64.12 %	22.17 %	14.02 %
2028e	64.12 %	22.68 %	13.59 %
2029e	64.12 %	21.88 %	13.85 %

Date	Genomma Lab Internacional SAB de CV Sales per Share	Genomma Lab Internacional SAB de CV EBIT per share	Genomma Lab Internacional SAB de CV Earnings per Share
2029e	26.93 undefined	0 undefined	3.73 undefined
2028e	24.2 undefined	0 undefined	3.29 undefined
2027e	23.58 undefined	0 undefined	3.3 undefined
2026e	21.61 undefined	0 undefined	2.73 undefined
2025e	20.58 undefined	0 undefined	2.45 undefined
2024	19.02 undefined	4 undefined	1.53 undefined
2023	17.2 undefined	3.35 undefined	1.07 undefined
2022	16.93 undefined	3.27 undefined	1.4 undefined
2021	15.37 undefined	3.03 undefined	1.3 undefined
2020	13.71 undefined	2.74 undefined	1.39 undefined
2019	12.55 undefined	2.3 undefined	0.74 undefined
2018	11.52 undefined	2.37 undefined	1.08 undefined
2017	12.68 undefined	2.71 undefined	1.34 undefined
2016	10.79 undefined	0.27 undefined	-1.6 undefined
2015	10.53 undefined	-0.93 undefined	-1.02 undefined
2014	11.01 undefined	2.33 undefined	1.38 undefined
2013	10.83 undefined	2.79 undefined	1.67 undefined
2012	9.35 undefined	2.38 undefined	1.49 undefined
2011	7.68 undefined	1.96 undefined	1.33 undefined
2010	5.95 undefined	1.53 undefined	1.02 undefined
2009	4.18 undefined	1.03 undefined	0.72 undefined
2008	2.48 undefined	0.64 undefined	0.49 undefined
2007	2.22 undefined	0.54 undefined	0.36 undefined
2006	1.7 undefined	0.33 undefined	0.21 undefined
2005	0.82 undefined	-0.15 undefined	-0.14 undefined

	Sales per Share	EBIT per share	Earnings per Share
2005	0.82 MXN	-0.15 MXN	-0.14 MXN
2006	1.7 MXN	0.33 MXN	0.21 MXN
2007	2.22 MXN	0.54 MXN	0.36 MXN
2008	2.48 MXN	0.64 MXN	0.49 MXN
2009	4.18 MXN	1.03 MXN	0.72 MXN
2010	5.95 MXN	1.53 MXN	1.02 MXN
2011	7.68 MXN	1.96 MXN	1.33 MXN
2012	9.35 MXN	2.38 MXN	1.49 MXN
2013	10.83 MXN	2.79 MXN	1.67 MXN
2014	11.01 MXN	2.33 MXN	1.38 MXN
2015	10.53 MXN	-0.93 MXN	-1.02 MXN
2016	10.79 MXN	0.27 MXN	-1.6 MXN
2017	12.68 MXN	2.71 MXN	1.34 MXN
2018	11.52 MXN	2.37 MXN	1.08 MXN
2019	12.55 MXN	2.3 MXN	0.74 MXN
2020	13.71 MXN	2.74 MXN	1.39 MXN
2021	15.37 MXN	3.03 MXN	1.3 MXN
2022	16.93 MXN	3.27 MXN	1.4 MXN
2023	17.2 MXN	3.35 MXN	1.07 MXN
2024	19.02 MXN	4 MXN	1.53 MXN
2025e	20.58 MXN	0 MXN	2.45 MXN
2026e	21.61 MXN	0 MXN	2.73 MXN
2027e	23.58 MXN	0 MXN	3.3 MXN
2028e	24.2 MXN	0 MXN	3.29 MXN
2029e	26.93 MXN	0 MXN	3.73 MXN

	Number of stocks
2005	843 M Aktien
2006	843 M Aktien
2007	843 M Aktien
2008	1.06 B Aktien
2009	1.06 B Aktien
2010	1.05 B Aktien
2011	1.05 B Aktien
2012	1.05 B Aktien
2013	1.05 B Aktien
2014	1.05 B Aktien
2015	1.05 B Aktien
2016	1.05 B Aktien
2017	952.49 M Aktien
2018	1.02 B Aktien
2019	1.01 B Aktien
2020	1.01 B Aktien
2021	1.01 B Aktien
2022	993.23 M Aktien
2023	957.34 M Aktien
2024	978.43 M Aktien
2025e	978.43 M Aktien
2026e	978.43 M Aktien
2027e	978.43 M Aktien
2028e	978.43 M Aktien
2029e	978.43 M Aktien

Date	Genomma Lab Internacional SAB de CV Dividend
2029e	0.86 undefined
2028e	0.86 undefined
2027e	0.86 undefined
2026e	0.86 undefined
2025e	0.85 undefined
2024	0.8 undefined
2023	0.59 undefined
2022	0.76 undefined
2021	0.38 undefined

	Dividend	Dividend (Estimate)
2005	0 MXN	0 MXN
2006	0 MXN	0 MXN
2007	0 MXN	0 MXN
2008	0 MXN	0 MXN
2009	0 MXN	0 MXN
2010	0 MXN	0 MXN
2011	0 MXN	0 MXN
2012	0 MXN	0 MXN
2013	0 MXN	0 MXN
2014	0 MXN	0 MXN
2015	0 MXN	0 MXN
2016	0 MXN	0 MXN
2017	0 MXN	0 MXN
2018	0 MXN	0 MXN
2019	0 MXN	0 MXN
2020	0 MXN	0 MXN
2021	0.38 MXN	0 MXN
2022	0.76 MXN	0 MXN
2023	0.59 MXN	0 MXN
2024	0.8 MXN	0 MXN
2025e	0 MXN	0.85 MXN
2026e	0 MXN	0.86 MXN
2027e	0 MXN	0.86 MXN
2028e	0 MXN	0.86 MXN
2029e	0 MXN	0.86 MXN

Date	Genomma Lab Internacional SAB de CV Payout ratio
2029e	44.1 %
2028e	44.68 %
2027e	44.05 %
2026e	43.58 %
2025e	46.41 %
2024	42.16 %
2023	42.16 %
2022	54.92 %
2021	29.41 %
2020	42.16 %
2019	42.16 %
2018	42.16 %
2017	42.16 %
2016	42.16 %
2015	42.16 %
2014	42.16 %
2013	42.16 %
2012	42.16 %
2011	42.16 %
2010	42.16 %
2009	42.16 %
2008	42.16 %
2007	42.16 %
2006	42.16 %
2005	42.16 %

	Payout ratio
2005	42.16 %
2006	42.16 %
2007	42.16 %
2008	42.16 %
2009	42.16 %
2010	42.16 %
2011	42.16 %
2012	42.16 %
2013	42.16 %
2014	42.16 %
2015	42.16 %
2016	42.16 %
2017	42.16 %
2018	42.16 %
2019	42.16 %
2020	42.16 %
2021	29.41 %
2022	54.92 %
2023	42.16 %
2024	42.16 %
2025e	46.41 %
2026e	43.58 %
2027e	44.05 %
2028e	44.68 %
2029e	44.1 %

Date	EPS Estimate	EPS Actual	Quarterly report
3/31/2025	0.46	0.5 (8.93 %)	2025 Q1
12/31/2024	0.53	0.47 (-11.39 %)	2024 Q4
9/30/2024	0.5	0.66 (31.16 %)	2024 Q3
6/30/2024	0.46	0.67 (47.06 %)	2024 Q2
3/31/2024	0.43	0.39 (-8.96 %)	2024 Q1
12/31/2023	0.17	-0.12 (-169.2 %)	2023 Q4
9/30/2023	0.47	0.39 (-16.88 %)	2023 Q3
6/30/2023	0.43	0.43 (0.54 %)	2023 Q2
3/31/2023	0.39	0.37 (-4.54 %)	2023 Q1
12/31/2022	0.4	0.27 (-32.69 %)	2022 Q4
9/30/2022	0.44	0.4 (-9.71 %)	2022 Q3
6/30/2022	0.44	0.4 (-8.8 %)	2022 Q2
3/31/2022	0.45	0.34 (-25.26 %)	2022 Q1
12/31/2021	0.42	0.36 (-13.27 %)	2021 Q4
9/30/2021	0.42	0.39 (-7.82 %)	2021 Q3
6/30/2021	0.41	0.38 (-6.4 %)	2021 Q2
3/31/2021	0.38	0.32 (-15.21 %)	2021 Q1
12/31/2020	0.33	0.33 (0.3 %)	2020 Q4
9/30/2020	0.33	0.4 (20.66 %)	2020 Q3
6/30/2020	0.36	0.36 (-0.58 %)	2020 Q2
3/31/2020	0.33	0.37 (12.46 %)	2020 Q1
12/31/2019	0.28	0.25 (-11.85 %)	2019 Q4
9/30/2019	0.28	0.72 (155.77 %)	2019 Q3
6/30/2019	0.3	0.24 (-18.88 %)	2019 Q2
3/31/2019	0.28	0.25 (-9.22 %)	2019 Q1
12/31/2018	0.22	0.25 (12.66 %)	2018 Q4
9/30/2018	0.32	0.23 (-28.57 %)	2018 Q3
6/30/2018	0.32	0.31 (-2.49 %)	2018 Q2
3/31/2018	0.42	0.4 (-4.35 %)	2018 Q1
12/31/2017	0.32	0.36 (12.32 %)	2017 Q4
9/30/2017	0.36	0.24 (-32.77 %)	2017 Q3
6/30/2017	0.38	0.29 (-22.75 %)	2017 Q2
3/31/2017	0.32	0.46 (43.62 %)	2017 Q1
12/31/2016	0.43	0.2 (-51.91 %)	2016 Q4
9/30/2016	0.3	0.49 (64.21 %)	2016 Q3
6/30/2016	0.26	0.35 (35.08 %)	2016 Q2
3/31/2016	0.18	0.35 (90.32 %)	2016 Q1
12/31/2015	0.3	-1.67 (-664.57 %)	2015 Q4
9/30/2015	0.36	0.18 (-50.29 %)	2015 Q3
6/30/2015	0.3	0.38 (26.77 %)	2015 Q2
3/31/2015	0.2	0.13 (-35.64 %)	2015 Q1
12/31/2014	0.84	0.49 (-42.24 %)	2014 Q4
9/30/2014	0.52	0.45 (-13.3 %)	2014 Q3
6/30/2014	0.33	0.29 (-12.25 %)	2014 Q2
3/31/2014	0.23	0.15 (-34.64 %)	2014 Q1
12/31/2013	0.82	0.8 (-2.88 %)	2013 Q4
9/30/2013	0.44	0.44 (-0.83 %)	2013 Q3
6/30/2013	0.32	0.3 (-5.27 %)	2013 Q2
3/31/2013	0.13	1.49 (1,023.68 %)	2013 Q1
12/31/2012	0.71	0.71 (-0.56 %)	2012 Q4
9/30/2012	0.39	0.38 (-3.65 %)	2012 Q3
6/30/2012	0.31	0.26 (-15.03 %)	2012 Q2
3/31/2012	0.18	0.13 (-30.28 %)	2012 Q1
12/31/2011	0.59	0.57 (-3.31 %)	2011 Q4
9/30/2011	0.34	0.37 (8.04 %)	2011 Q3
6/30/2011	0.26	0.25 (-2.98 %)	2011 Q2
3/31/2011	0.13	0.13 (4.8 %)	2011 Q1
12/31/2010	0.44	0.44 (0.09 %)	2010 Q4
9/30/2010	0.26	0.27 (6.67 %)	2010 Q3
6/30/2010	0.21	0.22 (2.82 %)	2010 Q2
9/30/2009	0.19	0.18 (-7.26 %)	2009 Q3
3/31/2009	0.07	0.07 (-0.56 %)	2009 Q1

%	Name	Stocks	Change	Date
31.67074 %	Herrera Aspa (Rodrigo Alonso)	309,876,000	1,973,600	4/30/2024
6.08233 %	Fidelity Management & Research Company LLC	59,511,361	-34,481	12/31/2024
2.71581 %	Skagen AS	26,572,260	-197,172	12/31/2024
2.37134 %	Norges Bank Investment Management (NBIM)	23,201,925	22,069,125	12/31/2024
2.35993 %	The Vanguard Group, Inc.	23,090,219	28,700	1/31/2025
2.24949 %	Impulsora del Fondo México, S.C.	22,009,697	348,464	1/31/2025
1.83266 %	BlackRock Institutional Trust Company, N.A.	17,931,250	2,045,107	1/31/2025
1.62128 %	Moneda S.A. Administradora General de Fondos	15,863,042	15,863,042	6/30/2023
1.42486 %	Wellington Management Company, LLP	13,941,219	-1,053,284	12/31/2024
1.30329 %	Pacific Asset Management LLP	12,751,796	285,100	6/30/2024
1.19050 %	Dimensional Fund Advisors, L.P.	11,648,240	-363,073	12/31/2024
0.93381 %	Swedbank Robur Fonder AB	9,136,714	1,268,407	12/31/2024
0.93070 %	INVESCO Asset Management Limited	9,106,200	-40,600	12/31/2024
0.62173 %	BlackRock Mexico Operadora SA de CV SOFI	6,083,212	-154,391	1/31/2025
0.48414 %	Tidal Investments LLC	4,737,000	0	1/31/2025
0.44897 %	American Century Investment Management, Inc.	4,392,831	1,034,413	12/31/2024
0.44837 %	Calamos Advisors LLC	4,386,970	0	12/31/2024
0.33909 %	Sanlam Investment Management (Pty) Ltd.	3,317,776	-969,831	12/31/2024
0.33023 %	BlackRock Advisors (UK) Limited	3,231,049	3,300	1/31/2025
0.25000 %	Allianz Global Investors GmbH	2,446,100	121,900	12/31/2024
0.24432 %	Invesco Advisers, Inc.	2,390,500	0	12/31/2024
0.18015 %	RAM Active Investments S.A.	1,762,645	705,597	12/31/2024
0.17366 %	State Street Global Advisors (US)	1,699,126	0	1/31/2025
0.17193 %	Mellon Investments Corporation	1,682,181	-97,072	1/31/2025
0.17152 %	Actinver S.A. de C.V.	1,678,242	57,500	1/31/2025
0.14045 %	Dimensional Fund Advisors, Ltd.	1,374,191	0	12/31/2024
0.13848 %	California Public Employees' Retirement System	1,354,900	-65,800	6/30/2023
0.13714 %	EFG Asset Management (UK) Limited	1,341,853	-42,437	10/31/2024
0.13664 %	Genesis Investment Management, LLP	1,336,947	0	12/31/2024
0.13619 %	Robeco Institutional Asset Management B.V.	1,332,500	0	12/31/2024
0.13614 %	First Trust Advisors L.P.	1,331,994	-47,665	12/31/2024
0.12872 %	Storebrand Kapitalforvaltning AS	1,259,419	-94,196	11/30/2024
0.12763 %	Operadora de Fondos Banorte Ixe S.A. de C.V.	1,248,809	-100,000	1/31/2025
0.12750 %	Boston Partners	1,247,500	318,800	11/30/2024
0.11909 %	BTG Pactual WM Gestão de Recursos Ltda.	1,165,246	-145,287	1/31/2025
0.11868 %	Ironhorse Capital LLC	1,161,240	-24,318	12/31/2024
0.11496 %	Sura Investment Management México, S.A. de C.V.	1,124,788	260,290	1/31/2025
0.10220 %	ÖKOWORLD LUX S.A.	1,000,000	0	8/31/2024
0.10173 %	Nomura Asset Management (UK) Ltd.	995,314	995,314	10/31/2024
0.09526 %	Seven Canyons Advisors, LLC	932,064	0	12/31/2024
0.06628 %	Ashmore Investment Management Limited	648,500	-36,500	12/31/2024
0.06166 %	SEI Investments Management Corporation	603,305	78,808	1/31/2025
0.06074 %	Mayr Investment Managers GmbH	594,300	0	11/30/2024
0.05979 %	Virtus Investment Advisers, Inc.	585,000	0	12/31/2024
0.05956 %	Nuveen LLC	582,800	0	11/30/2024
0.05632 %	azValor Asset Management SGIIC, SAU	551,062	110,195	6/30/2024
0.05553 %	Fidelity Investments Canada ULC	543,344	130,279	12/31/2024
0.05542 %	Lazard Asset Management, L.L.C.	542,265	94,409	12/31/2024
0.05052 %	Apo Asset Management GmbH	494,318	0	8/31/2024
0.04993 %	Acadian Asset Management LLC	488,570	0	12/31/2024
0.04614 %	Grantham Mayo Van Otterloo & Co LLC	451,400	394,500	11/30/2024
0.04294 %	MFS Investment Management	420,124	2,044	1/31/2025
0.04008 %	Compass Investments de México, S.A. - Sociedad Operadora de Sociedades	392,174	-55,662	1/31/2025
0.03846 %	Sherpa Capital	376,290	5,920	1/31/2025
0.03827 %	Fidelity Institutional Asset Management	374,486	0	1/31/2025
0.03504 %	Geode Capital Management, L.L.C.	342,848	0	12/31/2024
0.03004 %	Victory Capital Management Inc.	293,956	293,956	12/31/2024
0.02947 %	California State Teachers Retirement System	288,309	288,309	6/30/2024
0.02902 %	Axiom Investors	283,900	246,200	12/31/2024
0.02851 %	Principal Administradora General de Fondos S.A.	278,919	-35,000	1/31/2025
0.02718 %	DFA Australia Ltd.	265,979	4,700	12/31/2024
0.02519 %	Zurich Chile Asset Management Administradora General de Fondos S.A.	246,515	6,515	6/30/2023
0.02281 %	State Street Global Advisors (UK) Ltd.	223,139	0	1/31/2025
0.02281 %	State Street Global Advisors Ireland Limited	223,139	-15,363	11/30/2024
0.02258 %	Parametric Portfolio Associates LLC	220,900	0	10/31/2024
0.01533 %	PEH Wertpapier AG	150,000	30,000	10/31/2024
0.01346 %	Serafin Asset Management AG	131,700	0	12/31/2024
0.01346 %	Artico Partners AG	131,700	0	9/30/2024
0.01346 %	Principal Fondos de Inversión, S.A. de C.V.	131,668	60,000	1/31/2025
0.01333 %	DNB Asset Management AS	130,400	0	12/31/2024
0.01134 %	Origin Asset Management LLP	111,000	0	1/31/2025
0.01133 %	Operadora Valmex de Fondos de Inversión, S.A. de C.V.	110,860	0	1/31/2025
0.00990 %	Vanguard Global Advisers LLC	96,822	0	1/31/2025
0.00920 %	Renta 4 Gestora, S.G.I.I.C., S.A.	90,059	268	6/30/2024
0.00884 %	JP Morgan Asset Management	86,542	0	12/31/2024
0.00721 %	LSV Asset Management	70,542	70,542	9/30/2024
0.00665 %	Compass Group, L.L.C.	65,081	-132,244	11/30/2024
0.00647 %	Avantis Investors	63,329	953	12/31/2024
0.00631 %	Vanguard Investments Australia Ltd.	61,722	-15,440	12/31/2024
0.00589 %	Operadora de Fondos GBM S.A.B. de C.V.	57,653	0	6/30/2024
0.00567 %	Wilmington Trust Investment Advisors, Inc.	55,522	-5,605	12/31/2024
0.00523 %	Irish Life Investment Managers Ltd.	51,125	0	1/31/2025
0.00513 %	HSBC Global Asset Management (UK) Limited	50,239	-9,100	11/30/2024
0.00301 %	Operadora Inbursa de Sociedades de Inversión, S.A. de C.V.	29,405	0	1/31/2025
0.00281 %	Vector Fondos S.A. de C.V. SOFI	27,460	-4,562	1/31/2025
0.00192 %	Northern Trust Investments, Inc.	18,800	0	1/31/2025
0.00189 %	Sumitomo Mitsui Trust Asset Management Co., Ltd.	18,465	18,465	3/31/2024
0.00135 %	Natixis Investment Managers SA	13,186	0	8/31/2023
0.00110 %	Monex Operadora de Fondos S.A. de C.V.	10,800	0	1/31/2025
0.00104 %	Dimensional Fund Advisors Canada ULC	10,200	0	10/31/2024
0.00084 %	Operadora de Fondo NAFINSA S.A. de C.V.	8,244	75	12/31/2024
0.00049 %	CI Global Asset Management	4,746	421	1/31/2025
0.00029 %	Operadora Mifel S.A. de C.V.	2,869	310	1/31/2025
0.00025 %	State Street Global Advisors Ltd. (Canada)	2,439	-148	12/31/2024
0 %	Fidelity Management & Research (Hong Kong) Limited	0	-754,788	10/31/2024
0 %	ITAU USA Asset Management Inc.	0	-325,459	6/30/2023
0 %	Skandia Operadora de Fondos, S.A. de C.V.	0	-301,200	12/31/2024
0 %	Finaccess México, S.A. de C.V.	0	-416,100	9/30/2024
0 %	Invex Operadora, S.A. de C.V.	0	-157,719	8/31/2023
0 %	Lingohr & Partner Asset Management GmbH	0	-127,200	11/30/2023

What values and corporate philosophy does Genomma Lab Internacional SAB de CV represent?

Genomma Lab Internacional SAB de CV represents a strong focus on innovation, quality, and consumer satisfaction. With a commitment to research and development, the company aims to provide innovative healthcare and personal care products to improve the lives of consumers. Genomma Lab Internacional SAB de CV's corporate philosophy revolves around integrity, transparency, and ethical practices, ensuring the highest standards in all aspects of its operations. The company continuously strives to meet customer needs and exceed expectations through its diverse portfolio of trusted brands. Genomma Lab Internacional SAB de CV's dedication towards excellence sets it apart in the industry.

In which countries and regions is Genomma Lab Internacional SAB de CV primarily present?

Genomma Lab Internacional SAB de CV is primarily present in Mexico and various countries across Latin America. With a strong presence in Mexico, the company has expanded its operations to other key regions including Brazil, Central America, Colombia, and Argentina. Genomma Lab focuses on developing, manufacturing, and distributing a wide range of personal care and pharmaceutical products. With its commitment to providing high-quality health and wellness solutions, the company continues to strengthen its position in these markets while also seeking opportunities for global expansion.

What significant milestones has the company Genomma Lab Internacional SAB de CV achieved?

Genomma Lab Internacional SAB de CV has achieved several significant milestones throughout its history. One notable milestone was the company's listing on the Mexican Stock Exchange in 2008, which marked its transition to a publicly traded company. Additionally, Genomma Lab has successfully expanded its product portfolio, with a strong focus on personal care and pharmaceutical products. The company's commitment to innovation and strategic acquisitions has led to its presence in over 100 countries worldwide. Genomma Lab's continued growth and market leadership have solidified its position as a prominent player in the global healthcare industry.

What is the history and background of the company Genomma Lab Internacional SAB de CV?

Genomma Lab Internacional SAB de CV is a renowned Mexican company specializing in the production and marketing of pharmaceutical and personal care products. Founded in 1996, Genomma Lab has grown to become one of the leading consumer healthcare companies in Latin America. With a diverse portfolio of well-known brands, they offer a wide range of products, including over-the-counter medications, skincare, hair care, and oral care products. Genomma Lab is committed to innovation, quality, and providing affordable healthcare solutions to its customers. With a strong presence in various Latin American countries and a solid track record, Genomma Lab continues to strengthen its position in the global market.

Who are the main competitors of Genomma Lab Internacional SAB de CV in the market?

The main competitors of Genomma Lab Internacional SAB de CV in the market are well-established pharmaceutical companies such as Johnson & Johnson, Procter & Gamble, and Unilever. These companies compete with Genomma Lab in various product categories, including personal care, over-the-counter medicines, and healthcare products. Despite facing competition from these global giants, Genomma Lab has managed to establish a strong presence in the market with its diverse product portfolio and effective marketing strategies.

In which industries is Genomma Lab Internacional SAB de CV primarily active?

Genomma Lab Internacional SAB de CV is primarily active in the healthcare and personal care industries.

What is the business model of Genomma Lab Internacional SAB de CV?

The business model of Genomma Lab Internacional SAB de CV revolves around the development, production, and marketing of pharmaceutical and personal care products. With a focus on innovation and quality, Genomma Lab aims to provide effective solutions for consumers' health and well-being. The company utilizes its extensive research and development capabilities to create a diverse range of products that cater to various market segments. Genomma Lab's business model combines strategic partnerships, robust distribution networks, and aggressive marketing strategies to promote its brand and drive sales. By constantly adapting to market trends and consumer demands, Genomma Lab strives to maintain its position as a leading player in the healthcare and personal care industry.

What is the P/E ratio of Genomma Lab Internacional SAB de CV 2025?

The P/E ratio cannot be calculated for Genomma Lab Internacional SAB de CV at the moment.

What is the P/S ratio of Genomma Lab Internacional SAB de CV 2025?

The P/S cannot be calculated for Genomma Lab Internacional SAB de CV currently.

What is the Quality Investing of Genomma Lab Internacional SAB de CV?

The Quality Investing for Genomma Lab Internacional SAB de CV is 5/10.

What is the revenue of Genomma Lab Internacional SAB de CV 2025?

The expected Genomma Lab Internacional SAB de CV revenue is 20.13 B MXN.

How high is the profit of Genomma Lab Internacional SAB de CV 2025?

The expected Genomma Lab Internacional SAB de CV profit is 2.4 B MXN.

What is the business model of Genomma Lab Internacional SAB de CV

Genomma Lab Internacional SAB de CV is a leading pharmaceutical and health products company based in Mexico. The company specializes in the development, manufacturing, and distribution of over-the-counter (OTC) and cosmetic products. The company divides its business activities into six segments: 1. Medical Products: Genomma Lab offers a range of medical products for the treatment of various diseases such as arthritis, diabetes, dehydration, stomach problems, and other conditions. 2. Cosmetics: Genomma Lab offers a wide range of cosmetic products that can improve the skin's appearance. These include products for acne, skin blemishes, scars, and stretch marks. 3. Hair Care Products: The company offers products in this segment that help structure the hair, improve hair shine, and work against hair loss and damage. 4. Foot Care: Genomma Lab offers a wide selection of foot care products that effectively tackle fungal infections, sweaty feet, and general foot discomfort. 5. Women's Health: Genomma Lab has developed products that can help women with various issues such as menstrual discomfort, vaginal fungus, and sexual dysfunction. 6. Animal Health: Under this segment, Genomma Lab offers a range of products that can treat and heal dogs, cats, and other pets. Genomma Lab also markets well-known brands such as Tío Nacho, Cicatricure, Goicoechea, Asepxia, and Silka Medic. The company has a broad distribution network and sells its products in various countries such as Mexico, the United States, Canada, Colombia, Chile, Peru, and others. Genomma Lab's business model is based on the utilization of advanced technologies and collaboration with leading experts to develop high-quality products. The company places great emphasis on research and development and has established multiple R&D centers. Genomma Lab pursues a differentiated distribution model based on its direct sales channel. Through the direct sales model, Genomma can deliver its products directly to the end customer and thus be more responsive to customer needs. The company also works with retail partners to sell its products in physical stores and online platforms. In summary, Genomma Lab's business model is focused on the development and marketing of innovative OTC and cosmetic products. The company has established itself in various business areas and pursues a differentiated distribution strategy to sell its products both online and in retail. The company leverages advancements in technology and places great importance on research and development to remain a trusted company.

What is the Genomma Lab Internacional SAB de CV dividend?

Genomma Lab Internacional SAB de CV pays a dividend of 0.76 MXN distributed over payouts per year.

How often does Genomma Lab Internacional SAB de CV pay dividends?

The dividend cannot currently be calculated for Genomma Lab Internacional SAB de CV or the company does not pay out a dividend.

What is the Genomma Lab Internacional SAB de CV ISIN?

The ISIN of Genomma Lab Internacional SAB de CV is MX01LA010006.

What is the Genomma Lab Internacional SAB de CV WKN?

The WKN of Genomma Lab Internacional SAB de CV is A0Q4TC.

What is the Genomma Lab Internacional SAB de CV ticker?

The ticker of Genomma Lab Internacional SAB de CV is LABB.MX.

How much dividend does Genomma Lab Internacional SAB de CV pay?

Over the past 12 months, Genomma Lab Internacional SAB de CV paid a dividend of 0.8 MXN . This corresponds to a dividend yield of about . For the coming 12 months, Genomma Lab Internacional SAB de CV is expected to pay a dividend of 0.86 MXN.

What is the dividend yield of Genomma Lab Internacional SAB de CV?

The current dividend yield of Genomma Lab Internacional SAB de CV is .

When does Genomma Lab Internacional SAB de CV pay dividends?

Genomma Lab Internacional SAB de CV pays a quarterly dividend. This is distributed in the months of October, January, April, July.

How secure is the dividend of Genomma Lab Internacional SAB de CV?

Genomma Lab Internacional SAB de CV paid dividends every year for the past 9 years.

What is the dividend of Genomma Lab Internacional SAB de CV?

For the upcoming 12 months, dividends amounting to 0.86 MXN are expected. This corresponds to a dividend yield of 4.1 %.

In which sector is Genomma Lab Internacional SAB de CV located?

Genomma Lab Internacional SAB de CV is assigned to the 'Health' sector.

Wann musste ich die Aktien von Genomma Lab Internacional SAB de CV kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Genomma Lab Internacional SAB de CV from 7/1/2025 amounting to 0.2 MXN, you needed to have the stock in your portfolio before the ex-date on 6/30/2025.

When did Genomma Lab Internacional SAB de CV pay the last dividend?

The last dividend was paid out on 7/1/2025.

What was the dividend of Genomma Lab Internacional SAB de CV in the year 2024?

In the year 2024, Genomma Lab Internacional SAB de CV distributed 0.588 MXN as dividends.

In which currency does Genomma Lab Internacional SAB de CV pay out the dividend?

The dividends of Genomma Lab Internacional SAB de CV are distributed in MXN.

Scope 1 - Direct Emissions	2,737.47
Scope 2 - Indirect emissions from purchased energy	4,041.11
Scope 3 - Indirect emissions within the value chain	43,466.98
Total CO₂ emissions	6,778.58
CO₂ reduction strategy
Coal energy
Nuclear power
Animal experiments
Fur & Leather
Pesticides
Palm Oil
Tobacco
Genetically modified organisms
Climate concept
Sustainable forestry
Recycling regulations
Environmentally friendly packaging
Hazardous substances
Fuel consumption and efficiency
Water consumption and efficiency

Percentage of female employees	50.3
Percentage of women in management
Percentage of Asian employees
Share of Asian management
Percentage of Hispanic/Latino employees
Hispano/Latino Management share
Percentage of Black employees
Black Management Share
Percentage of white employees
White Management Share
Adult content
Alcohol
Weapons
Firearms
Gambling
Military contracts
Human rights concept
Privacy concept
Occupational health and safety
Catholic

Environmental reporting
Stakeholder Engagement
Call Back Policies
Antitrust law

Stock Exchange	Genomma Lab Internacional SAB de CV Ticker
FRANKFURT	GEKA.F
MEX	LABB.MX
PNK	GNMLF

Genomma Lab Internacional SAB de CV Ticker	Genomma Lab Internacional SAB de CV FIGI
LABB:MM	BBG000G12MW3
LABB:MF	BBG000G12N97
GEKA:GR	BBG000HLBK52
GEKA:GF	BBG000HLBKZ9
GNMLF:US	BBG002QM6BQ9
GNMLF:PQ	BBG002QM6C41
GNMLF:UV	BBG002QM6C69
LABBMXN:X2	BBG00JRTKFH1
LABBMXN:XB	BBG00JRTKFK7
LABBMXN:XH	BBG00JRTKFN4
LABBMXN:XF	BBG00JRTKFQ1
LABBMXN:XE	BBG00JRTKFT8
LABBMXN:XJ	BBG00JRTKFV5
LABBMXN:XL	BBG00JRTKFX3
LABBMXN:XG	BBG00JRTKFY2
LABBMXN:XO	BBG00JRTKG07
LABBMXN:XS	BBG00JRTKG52
LABBMXN:XA	BBG00JRTKG61
LABBMXN:E1	BBG00JRTKG89
LABBMXN:XT	BBG00JRTKG98
LABBMXN:XW	BBG00JRTKGB5
LABBMXN:XU	BBG00JRTKGD3
LABBMXN:XV	BBG00JRTKGF1
LABBMXN:XM	BBG00JRTKGG0
LABBMXN:XQ	BBG00JRTKGK5
LABBMXN:XX	BBG00JRTKGL4
LABBMXN:XZ	BBG00JRTKGN2
LABBMXN:EU	BBG00JRTKGV3
LABB:MU	BBG00JX0PJG5
LABBEUR:X2	BBG00K170WZ9
LABBEUR:XB	BBG00K170X05
LABBEUR:XH	BBG00K170X23
LABBEUR:XF	BBG00K170X50
LABBEUR:XE	BBG00K170X78
LABBEUR:XJ	BBG00K170X87
LABBEUR:XL	BBG00K170X96
LABBEUR:XG	BBG00K170XB3
LABBEUR:XO	BBG00K170XC2
LABBEUR:XS	BBG00K170XH7
LABBEUR:XA	BBG00K170XJ5
LABBEUR:E1	BBG00K170XK3
LABBEUR:XT	BBG00K170XL2
LABBEUR:XW	BBG00K170XM1
LABBEUR:XU	BBG00K170XP8
LABBEUR:XV	BBG00K170XQ7
LABBEUR:XM	BBG00K170XR6
LABBEUR:XQ	BBG00K170XT4
LABBEUR:XX	BBG00K170XV1
LABBEUR:XZ	BBG00K170XW0
LABBEUR:EU	BBG00K170XY8
LABBBRL:EO	BBG00KDTDPC4
LABBBRL:XH	BBG00KDTDPG0
LABBBRL:XF	BBG00KDTDPJ7
LABBBRL:XE	BBG00KDTDPL4
LABBBRL:XJ	BBG00KDTDPM3
LABBBRL:XL	BBG00KDTDPN2
LABBBRL:XG	BBG00KDTDPP0
LABBBRL:XO	BBG00KDTDPQ9
LABBBRL:XS	BBG00KDTDPV3
LABBBRL:XA	BBG00KDTDPW2
LABBBRL:E1	BBG00KDTDPX1
LABBBRL:XT	BBG00KDTDPY0
LABBBRL:XW	BBG00KDTDPZ9
LABBBRL:XU	BBG00KDTDQ05
LABBBRL:XV	BBG00KDTDQ14
LABBBRL:XM	BBG00KDTDQ23
LABBBRL:XQ	BBG00KDTDQ41
LABBBRL:XX	BBG00KDTDQ50
LABBBRL:XZ	BBG00KDTDQ69
LABBBRL:EU	BBG00KDTDQ87

2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025e	2026e	2027e	2028e	2029e
0.69	1.43	1.87	2.63	4.43	6.26	8.08	9.8	11.36	11.54	11.04	11.32	12.08	11.79	12.71	13.87	15.49	16.82	16.47	18.61	20.13	21.15	23.07	23.68	26.35
-	106.20	31.07	40.36	68.31	41.56	28.91	21.36	15.93	1.58	-4.32	2.48	6.73	-2.35	7.78	9.11	11.66	8.60	-2.09	12.99	8.20	5.03	9.11	2.63	11.28
78.07	75.79	73.36	74.82	72.02	71.02	69.50	68.76	69.92	69.34	65.79	67.87	67.24	65.83	63.70	61.92	61.75	60.43	61.23	64.12	59.26	56.42	51.71	50.39	45.28
0.54	1.08	1.37	1.97	3.19	4.45	5.61	6.74	7.94	8	7.27	7.68	8.12	7.76	8.1	8.59	9.56	10.16	10.08	11.93	0	0	0	0	0
-0.11	0.18	0.3	0.52	0.76	1.07	1.4	1.57	1.75	1.44	-1.07	-1.68	1.28	1.11	0.75	1.4	1.31	1.39	1.03	1.49	2.4	2.67	3.23	3.22	3.65
-	-257.89	68.89	69.74	47.09	41.37	30.20	12.03	11.95	-17.58	-173.96	57.30	-176.13	-13.29	-32.46	87.32	-6.84	6.27	-26.13	45.52	60.42	11.52	21.04	-0.53	13.46
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
0.84	0.84	0.84	1.06	1.06	1.05	1.05	1.05	1.05	1.05	1.05	1.05	0.95	1.02	1.01	1.01	1.01	0.99	0.96	0.98	0	0	0	0	0
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

Professional-grade financial intelligence

Price

Price

TickerLABB.MX

ISINMX01LA010006

WKNA0Q4TC

Genomma Lab Internacional SAB de CV stock price

Price

Overview

Intraday Feature

Total Return and Relative Price Change

Interpretation and Investment

Genomma Lab Internacional SAB de CV Stock Price History

Genomma Lab Internacional SAB de CV Revenue, EBIT, Net Income MX01LA010006 · A0Q4TC

Revenue, EBIT and Profit

Understanding Revenue, EBIT, and Income

Yearly Analysis and Comparisons

Utilizing Expectations for Investment

Investment Insights

Genomma Lab Internacional SAB de CV Revenue, EBIT and net profit per share

Genomma Lab Internacional SAB de CV Income Statement, Balance Sheet, Cash Flow Statement

Keystats

Revenue and Growth

Gross Margin

EBIT and EBIT Margin

Income and Growth

Shares Outstanding

Interpreting Year to Year Comparison

Expectations and Predictions

Balance Sheet

Understanding the Balance Sheet

Assets

Liabilities

Equity

Year-to-Year Analysis

Interpreting the Data

Genomma Lab Internacional SAB de CV stock margins MX01LA010006 · A0Q4TC

Margin

Understanding Gross Margin

EBIT Margin Analysis

Revenue Margin Insights

Interpreting Expectations

Comparative Analysis

Genomma Lab Internacional SAB de CV Margin History

Genomma Lab Internacional SAB de CV Stock Sales Revenue, EBIT, Earnings per Share MX01LA010006 · A0Q4TC

Revenue, EBIT and Earnings per share

Revenue Per Share

EBIT Per Share

Income Per Share

Expected Values

Genomma Lab Internacional SAB de CV Revenue, EBIT and net profit per share

Genomma Lab Internacional SAB de CV business model

Genomma Lab Internacional SAB de CV SWOT Analysis

Strengths

Weaknesses

Opportunities

Threats

The World’s Best Investors Are On Eulerpool

Genomma Lab Internacional SAB de CV Eulerpool Fair Value

Fair Value

Understanding Fair Value

Income-Based Fair Value

Revenue-Based Fair Value

Dividend-Based Fair Value

Expectations and Forecasts

Comparative Analysis

Genomma Lab Internacional SAB de CV historical P/E ratio, EBIT multiple, and P/S ratio

The World’s Best Investors Are On Eulerpool

Genomma Lab Internacional SAB de CV shares outstanding MX01LA010006 · A0Q4TC

Revenue, EBIT and Earnings per share

Revenue Per Share

EBIT Per Share

Income Per Share

Expected Values

Genomma Lab Internacional SAB de CV stock splits

Genomma Lab Internacional SAB de CV dividend history and estimates MX01LA010006 · A0Q4TC

Dividend

Dividend Overview

Interpretation and Use

Investment Strategy

Ticker
LABB.MX

ISIN
MX01LA010006

WKN
A0Q4TC